Skip to main content

Find Clinical Trials

Home
Conditions
Parkinsonian Disorders

Clinical trial condition

Parkinsonian Disorders

Explore clinical trials studying Parkinsonian Disorders. Study availability and eligibility vary by location and protocol.

3,328 public trials 611 recruiting studies

Refine in advanced search Browse all conditions

Parkinsonian Disorders trial results

Completed

SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations

NCT00406588

Conditions: Advanced Stage Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +7 more
Locations: Site 223 Birmingham, Alabama, United States

Site 220 La Jolla, California, United States

Site 211 San Francisco, California, United States

Site 214 Fort Lauderdale, Florida, United States

View all 87 locations

View Trial Details

Completed

Pharmacokinetic Study in Healthy Males

NCT02312232

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: CRST Turku, Finland

View Trial Details

Completed

Internet-CBT (Cognitive Behavioral Therapy) for Depression and Anxiety in Parkinsons Disease

NCT01545414

Conditions: Anxiety, Anxiety Disorders, Basal Ganglia Diseases, +18 more
Locations: Internetpsykiatrienehten (Internet Psychiatry Unit), Psykiatri Sydväst, SLSO Stockholm, Sweden

View Trial Details

Completed

Single Ascending Dose Study of PRX002 in Healthy Subjects

NCT02095171

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: San Antonio, Texas, United States

View Trial Details

Completed

The Effect of Rasagiline on Cognition in Parkinson's Disease

NCT01382342

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Butler Hospital Providence, Rhode Island, United States

View Trial Details

Completed

A Study of MK0657 in Parkinson's Disease Patients (0657-006)

NCT00505843

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism

NCT01759888

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Chang Gung Memory Hpspital Taoyuan, Taiwan

View Trial Details

Completed

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa

NCT02169453

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: Algorithme Pharma Inc Mount Royal, Quebec, Canada

View Trial Details

Completed

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

NCT00335153

Conditions: Advanced Parkinson's Disease, Basal Ganglia Diseases, Brain Diseases, +11 more
Locations: Site Reference ID/Investigator# 50065 Birmingham, Alabama, United States

Site Reference ID/Investigator# 50059 Fountain Valley, California, United States

Site Reference ID/Investigator# 50048 Los Angeles, California, United States

Site Reference ID/Investigator# 50076 Oceanside, California, United States

View all 83 locations

View Trial Details

Completed

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

NCT00360568

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Site Reference ID/Investigator# 45869 Birmingham, Alabama, United States

Site Reference ID/Investigator# 45834 Fountain Valley, California, United States

Site Reference ID/Investigator# 45854 Los Angeles, California, United States

Site Reference ID/Investigator# 45856 Oceanside, California, United States

View all 22 locations

View Trial Details